Premature ovarian failure 3 years after menarche in a 16-year-old girl following human papillomavirus vaccination

BMJ Case Reports 2012; doi:10.1136/bcr-2012-006879
Findings that shed new light on the possible pathogenesis of a disease or an adverse effect

Deirdre Therese Little

Summary
Premature ovarian failure in a well adolescent is a rare event. Its occurrence raises important questions about causation, which may signal other systemic concerns. This patient presented with amenorrhoea after identifying a change from her regular cycle to irregular and scant periods following vaccinations against human papillomavirus. She declined the oral contraceptives initially prescribed for amenorrhoea. The diagnostic tasks were to determine the reason for her secondary amenorrhoea and then to investigate for possible causes of the premature ovarian failure identified. Although the cause is unknown in 90% of cases, the remaining chief identifiable causes of this condition were excluded. Premature ovarian failure was then notified as a possible adverse event following this vaccination. The young woman was counselled regarding preservation of bone density, reproductive implications and relevant follow-up. This event could hold potential implications for population health and prompts further inquiry.

Journal Reference

Comments Are Closed